Did I just stumble upon an anime magazine that broke through the expected tropes and took itself seriously? Only one way to ...

The fourth installment in Zenith's tribute series to a famous anime is a stunning treat for mid-century chronograph ...

Think of it as timekeeping meets mythology: a sculpted horse, mid-leap, galloping across a dial of hand-engraved gold and ...

ETMarkets.com Looking ahead to 2028, Lupin is targeting 20 complex product launches across inhalation, injectables, and ophthalmic segments. Shares of pharmaceutical major Lupin rose as much as 3% to ...

Lupin is adding a U.S.-based pharmaceutical capacity to produce respiratory medicines. In recognition of its investment and job creation plans, Lupin will receive tax credits and incentives from the ...

LONDON, ROME and ZUG, Switzerland, Sept. 29, 2025 /PRNewswire/ -- Global pharma major Lupin Limited (Lupin) (BSE: 500257) (NSE: LUPIN) (REUTERS: LUPIN.BO) (BLOOMBERG: LPCIN), today announced its ...

Global pharma major Lupin Ltd on Wednesday (September 24) said it has received tentative approval from the United States Food and Drug Administration (FDA) for its generic version of an HIV drug. The ...

Indian pharmaceutical major Lupin on Friday announced the launch of a new nasal spray — Ipratropium Bromide Nasal Solution — in the United States market. The product is available in two strengths: ...

Shares of Lupin Ltd. edged 2.5 percent higher on Wednesday after the company announced the launch of Tolvaptan tablets in the US market, marking a key milestone in its US generics portfolio. The drug ...